Diabetes remission in drug-naïve patients with type 2 diabetes after dorzagliatin treatment: A prospective cohort study.

Jiao'e ZengShenglian GanNianrong MiYunfeng LiuXiaofei SuWenli ZhangJuan ZhangFang YuXiaolin DongMinmin HanJianfeng LuoYi ZhangFuxing Tang Jian-Hua Ma

Published in: Diabetes, obesity & metabolism (2023)

In drug-naïve patients with T2D, dorzagliatin treatment leads to stable glycaemic control and drug-free diabetes remission. Improvements in β-cell function and TIR in these patients are important contributors to diabetes remission.

Keyphrases

type diabetes
cardiovascular disease
glycemic control
disease activity
end stage renal disease
ejection fraction
newly diagnosed
emergency department
rheumatoid arthritis
combination therapy
adipose tissue
drug induced
smoking cessation